Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO)

Ciltas, Aydin; Aydin, Dincer; Sendur, Mehmet Ali; KEFELİ, UMUT; Unal, Olcun Umut; TAŞTEKİN, Didem; Akyol, Murat; Tanrikulu, Eda; Ustaalioglu, Basak Bala; ŞENER DEDE, DİDEM; Esbag, Onur; Inal, Ali; Bilir, Cemil; Bilici, Ahmet; Harputlu, Hakan; Berk, Veli; Sevinc, Alper; Ozdemir, Nuriye Yildirim; Yildirim, Emre; Sonkaya, Alper; Ustaoglu, Mehmet Ali; Gumus, Mahmut

Tarih

2016

Yazar

Ciltas, Aydin

Aydin, Dincer

Sendur, Mehmet Ali

KEFELİ, UMUT

Unal, Olcun Umut

TAŞTEKİN, Didem

Akyol, Murat

Tanrikulu, Eda

Ustaalioglu, Basak Bala

ŞENER DEDE, DİDEM

Esbag, Onur

Inal, Ali

Bilir, Cemil

Bilici, Ahmet

Harputlu, Hakan

Berk, Veli

Sevinc, Alper

Ozdemir, Nuriye Yildirim

Yildirim, Emre

Sonkaya, Alper

Ustaoglu, Mehmet Ali

Gumus, Mahmut

Üst veri

Tüm öğe kaydını göster

Özet

Purpose: Small bowel adenocarcinoma (SBA) is a rare tumor of the gastrointestinal system with poor prognosis. Since these are rarely encountered tumors, there are limited numbers of studies investigating systemic treatment in advanced SBA. The purpose of this study was to evaluate the prognostic factors and systemic treatments in patients with advance SBA.

Bağlantı

http://hdl.handle.net/20.500.12627/179402

Koleksiyonlar

Makale [92796]